跳至主要内容
临床试验/NCT00965471
NCT00965471已完成不适用

Effect of Chinese Traditional Medicine for Post Revascularization Treatment of Coronary Artery Disease

Guangzhou University of Chinese Medicine0 个研究点目标入组 940 人开始时间: 2006年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
940
主要终点
dead

研究概览

简要总结

The purpose of this study is to built the standard of Chinese Traditional Medicine test for Post percutaneous coronary artery intervention and coronary artery bypass graft,also for acute coronary syndrome,according to the multi-site、random large sample test.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
40 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • angina or CAD patient
  • deficiency of heart-QI and blockage of phlegm and blood stasis in chinese medicine
  • 1 week after operation,or 1week after drainage tube extraction for CABG
  • sign a informed consent

排除标准

  • severe cardia failure
  • severe renal inadequacy
  • complicating with malignant tumor,reactive alimentary tract hemorrhage and haematological systemic disorder etc.
  • psychotic
  • pregnant,lactation

研究组 & 干预措施

managed group

Experimental

干预措施: cipher prescription 1 (Drug)

control group

Placebo Comparator

干预措施: cipher prescription 2 (Drug)

结局指标

主要结局

dead

时间窗: 180±3days

次要结局

  • cardiovascular event(180±3days)

研究者

申办方类型
Other

相似试验